Additionally, we analyzed PCa expression data with clinical features, and found that ITGA1/ITGA2 mRNA levels were significantly lower in tumors with high tumor stage, Gleason score, lymph node and elevated PSA levels in multiple distinct patient cohorts (Figure 2l–s; Figure S2m–q, Supporting Information). This evidence concerns the gene ITGA1 and posterior cortical atrophy.